The present application relates to the fields of
medicine, modernization of
traditional Chinese medicine and
drug delivery, and specifically relates to a macrophage-derived
exosome loaded with aconite decoction extract, a preparation method thereof and application thereof in preparation of a
drug for preventing and treating
osteoarthritis. The effective component of the
drug preparation is macrophage-derived
exosome loaded with aconite decoction extract, which includes low-loading preparation WTDL-Exos and high-loading preparation WTDH-Exos and contains pharmaceutically acceptable excipients. The macrophage-derived
exosome is preferably derived from
mouse macrophage RAW264.7 and is extracted through
differential centrifugation and ultracentrifugation; the aconite decoction extract is prepared from prepared monkshood,
astragalus, honeyed licorice, ephedra and peony, and the concentration of the aconite decoction
mother liquor is 10 mg / mL; the drug-loaded exosome is obtained by co-incubation of the aconite decoction extract and the macrophage-derived exosome and purification, and the
loading rate is about 20%.
In vitro tests show that WTD-Exos has no obvious effect on
cell survival rate and is basically non-cytotoxic.
Western blot detection in animal experiments shows that the drug preparation can down-regulate the expression of MMP-13 and TNF-α in
synovial tissue and up-regulate the expression of
type II collagen, thereby improving joint synovial
inflammation and protecting
joint cartilage. The drug preparation can be used for preparing a drug for preventing and treating
osteoarthritis.